Expression of concern
Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A
Paper Information
Record ID:
36324
Author(s):
Journal:
Publication Date:
July 18, 2012
Retraction Date:
December 17, 2021
(3.9 years years ago)
Subjects:
Institutions:
- Department of Physiology, Pharmacology and Neuroscience, City University of New York Medical School, New York, New York 10031
- Department of Biology and Neuroscience, Graduate School of the City University of New York, New York, New York 10016
- Department of Science Education, Hofstra North Shore–Long Island Jewish School of Medicine, Hempstead, New York 11549-1000
- Pain Therapeutics, Inc., Austin, Texas 78731
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Society for Neuroscience
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1523/JNEUROSCI.2306-21.2021Citations (62)
62
Total Citations21
Post-Retraction(33.9%)
40
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
4
After 2+ years
1267
Days since retraction (latest)
Paper citing Reducing Amyloid-Related Alzheimer's Disease Patho...
Unknown Authors
Unknown Journal
Published: Jul 2014
2702 days before retraction
The nature, significance, and glucagon‐like peptide‐1 analog treatment of brain insulin resistance in Alzheimer's disease
Konrad Talbot, Hoau-Yan Wang
Alzheimer s & Dementia
Open Access
Published: Feb 2014
122 citations
122 citations
2876 days before retraction
Brain Insulin Resistance in Alzheimer's Disease and its Potential Treatment with GLP-1 Analogs
Konrad Talbot
Neurodegenerative Disease Management
Open Access
Published: Feb 2014
113 citations
113 citations
2876 days before retraction
Filamin A Promotes Dynamin-dependent Internalization of Hyperpolarization-activated Cyclic Nucleotide-gated Type 1 (HCN1) Channels and Restricts Ih in Hippocampal Neurons
Yoav Noam, Markus U. Ehrengruber, Annie Koh et al. (8 authors)
Journal of Biological Chemistry
Open Access
Published: Jan 2014
31 citations
31 citations
2899 days before retraction
Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer’s disease, hypertension, and cerebral amyloid angiopathy
Jing-Zhang Wang, Wangdong Zhu, Zhongxin Xu et al. (7 authors)
Medical Hypotheses
Published: Nov 2013
14 citations
14 citations
2941 days before retraction
The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity
Valeriy G. Ostapchenko, Flávio H. Beraldo, Amro H. Mohammad et al. (21 authors)
Journal of Neuroscience
Open Access
Published: Oct 2013
79 citations
79 citations
2984 days before retraction
Paper citing A specific amyloid-β protein assembly in the brain...
Unknown Authors
Unknown Journal
Published: Jul 2013
3091 days before retraction
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs
Journal of Alzheimer s Disease
Published: Feb 2013
27 citations
27 citations
3236 days before retraction
Complex roles of filamin-A mediated cytoskeleton network in cancer progression
Jingyin Yue, Steven Huhn, Zhiyuan Shen
Cell & Bioscience
Open Access
Published: Feb 2013
79 citations
79 citations
3241 days before retraction
Modulation of α7 Nicotinic Acetylcholine Receptor and Fibrillar Amyloid-β Interactions in Alzheimer's Disease Brain
Ruiqing Ni, Amelia Marutle, Agneta Nordberg
Journal of Alzheimer s Disease
Open Access
Published: Jan 2013
73 citations
73 citations
3263 days before retraction
Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer’s disease mice model
Peng Jin, Jina Kim, Dong‐Young Choi et al. (6 authors)
Journal of Neuroinflammation
Open Access
Published: Jan 2013
55 citations
55 citations
3268 days before retraction
Targeting filamin A reduces Alzheimer's signalling
Charlotte Harrison
Nature Reviews Drug Discovery
Open Access
Published: Aug 2012
1 citation
1 citation
3395 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #36325
Nov 10, 2021Quick Stats
Total Citations:
62
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025